High-dose therapy improves the bone remodelling compartment canopy coverage and bone formation in multiple myeloma
Maja Hinge1,2, Jean-Marie Delaisse1, Torben Plesner2
1Department of Clinical Cell Biology, Vejle/Lillebaelt Hospital, Institute of Regional Health Research, University of Southern Denmark, Vejle, Denmark.
British Journal of Haematology
|July 28, 2015
Summary
High-dose therapy improves bone remodeling in multiple myeloma (MM) by restoring bone formation and resorption coupling. This treatment enhances bone canopy coverage, reversing systemic bone loss associated with MM.
Area of Science:
- Oncology
- Bone Biology
- Hematology
Background:
- Multiple myeloma (MM) causes significant bone loss due to uncoupled bone remodeling.
- The bone remodeling compartment (BRC) canopy is crucial for coupled bone remodeling, and its loss is linked to bone disease.
Purpose of the Study:
- To investigate if high-dose therapy improves bone remodeling in MM patients.
- To assess the role of the BRC canopy in MM bone remodeling after treatment.
Main Methods:
- Histomorphometric analysis of bone marrow biopsies from 20 MM patients before and after high-dose melphalan with autologous stem cell transplantation.
- Comparison with 20 control patients with monoclonal gammopathy of undetermined significance.
Main Results:
- MM patients showed uncoupled bone formation/resorption and reduced canopy coverage.
- Successful anti-myeloma treatment increased bone surfaces with canopy and reduced eroded surfaces without canopy.
- Treatment response correlated with improved bone remodeling coupling and canopy coverage.
Conclusions:
- BRC canopy is critical for coupled bone formation and resorption.
- Systemic bone disease in MM can be reversed in patients responding to anti-myeloma therapy.
Related Concept Videos
01:40Bone Remodeling
41.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
41.1K
02:57Targeted Cancer Therapies
9.1K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
9.1K
01:31Osteoclasts in Bone Remodeling
4.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
4.8K
01:22Bone Marrow Sampling and Transplants
2.5K
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
2.5K